These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8935806)

  • 21. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration.
    Chlan-Fourney J; Ashe P; Nylen K; Juorio AV; Li XM
    Brain Res; 2002 Nov; 954(1):11-20. PubMed ID: 12393228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine.
    Millan MJ; Schreiber R; Monneyron S; Denorme B; Melon C; Queriaux S; Dekeyne A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):427-36. PubMed ID: 10087034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice.
    Philibin SD; Prus AJ; Pehrson AL; Porter JH
    Psychopharmacology (Berl); 2005 Jun; 180(1):49-56. PubMed ID: 15696329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inability of antipsychotics to antagonize the cueing properties of cocaine in rats.
    van Campenhout N; De Haes P; Meert TF
    Pharmacol Biochem Behav; 1999 Oct; 64(2):435-8. PubMed ID: 10515326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S; Bervoets K; Millan MJ
    Eur J Pharmacol; 1995 Jul; 280(2):R9-11. PubMed ID: 7589172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A; Janssen PF; Megens AA; Leysen JE
    Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats.
    Goudie A; Taylor A
    Psychopharmacology (Berl); 1998 Feb; 135(4):392-400. PubMed ID: 9539264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.
    Sanger DJ; Perrault G
    J Pharmacol Exp Ther; 1995 Feb; 272(2):708-13. PubMed ID: 7531764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
    Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH
    Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice.
    Donahue TJ; Hillhouse TM; Webster KA; Young R; De Oliveira EO; Porter JH
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3507-3520. PubMed ID: 28921163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further investigations of the interactions of antipsychotics with the (-)2,5-dimethoxy-4-methylamphetamine (DOM) discriminative stimulus.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Neuropharmacology; 1997 Oct; 36(10):1463-9. PubMed ID: 9423935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.
    Kehne JH; Baron BM; Carr AA; Chaney SF; Elands J; Feldman DJ; Frank RA; van Giersbergen PL; McCloskey TC; Johnson MP; McCarty DR; Poirot M; Senyah Y; Siegel BW; Widmaier C
    J Pharmacol Exp Ther; 1996 May; 277(2):968-81. PubMed ID: 8627580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
    Morisset S; Sahm UG; Traiffort E; Tardivel-Lacombe J; Arrang JM; Schwartz JC
    J Pharmacol Exp Ther; 1999 Feb; 288(2):590-6. PubMed ID: 9918563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.